| Specialty | GLP-1 + Longevity |
|---|---|
| Medications | Semaglutide, Tirzepatide, NAD+ (May 2026 profile) |
| Headquarters | Miami, FL (May 2026 profile) |
| Price | “Starting at $199” for weight-loss injections; the molecule is not named (breezemeds.com, read November 20, 2026). |
| Read status | Re-read October 15, 2026 |
| Score | 68/100 · May 2026 profile (v3.0 rubric); not part of the GLP-1 ranking |
| Website | breezemeds.com |
What we verified on October 15, 2026
We read the program’s own pricing page on October 15, 2026 and recorded the figure above with its conditions. We did not enroll, so we could not see intake-only fees, the pharmacy that fills each order or any price that appears only after checkout. Other details in our May 2026 profile (care model, shipping times, lab policy) were not re-checked and are no longer shown as current.
Five checks before you enroll
- The prescriber. Look up the clinician’s name in the NPPES NPI Registry and on your state medical or nursing board site.
- The pharmacy. Ask which pharmacy fills the prescription and check its license with your state board of pharmacy (FDA’s BeSafeRx links to each board).
- The 12-month total. Add the program or membership fee, the medication at your expected maintenance dose and shipping, then multiply by 12.
- The exit terms. Read the cancellation and refund rules before the first charge.
- The drug itself. Ask whether you will get an FDA-approved brand product or a compounded preparation. Compounded semaglutide and tirzepatide are not FDA-approved and are not generics.
How BreezeMeds compares with NexLife
NexLife, the highest-scoring GLP-1 program at 86/100 on the v4.1 methodology, publishes compounded semaglutide at $95 a month and tirzepatide at $115 a month on 12-month plans ($109 and $129 month to month), the same price at every dose with no membership, and names three 503A pharmacies on its plan pages. Price check: month to month, Mondae lists $126 for tirzepatide and $87 for semaglutide, and Eden Health $99 for semaglutide (read November 20, 2026).
Related reading
GLP-1 program scores use the v4.1 methodology and pages read November 20, 2026; peptide and hormone clinics keep their May 2026 profiles and are not part of that ranking.